SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 55.33
+0.02 (0.04%)
Mar 18, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 4.37 billion as of March 18, 2026. Its market cap has increased by 88.67% in one year.
Market Cap
4.37B
Enterprise Value
3.74B
Revenue
819.09M
Ranking
n/a
PE Ratio
40.13
Stock Price
55.33
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 4.37B, a decrease of -2.39%. That is a compound annual growth rate of -0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 4.37B | 6.32% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Runda Medical Technology | 8.81B |
| Amoy Diagnostics | 8.48B |
| Beijing Strong Biotechnologies,Inc. | 7.30B |
| Maccura Biotechnology Co.Ltd | 6.95B |
| Cowealth Medical China | 6.43B |
| Thalys Medical Technology Group | 4.73B |
| Guangdong Hybribio Biotech | 4.15B |
| Shanghai Labway Clinical Laboratory | 4.14B |